Quality of life is impaired in association with the need for prolonged postoperative therapy by somatostatin analogs in patients with acromegaly.
about
Effects of lanreotide Autogel primary therapy on symptoms and quality-of-life in acromegaly: data from the PRIMARYS study.Patient-focussed outcomes in acromegaly.Predictors of Quality of Life in Acromegaly: No Consensus on Biochemical ParametersQuality of life (QoL) impairments in patients with a pituitary adenoma: a systematic review of QoL studies.Impaired quality of life in patients with treated acromegaly despite long-term biochemically stable disease: Results from a 5-years prospective study.Update on quality of life in patients with acromegaly.General health status and intelligence scores of children of mothers with acromegaly do not differ from those of healthy mothers.Psychological profile and quality of life in patients with acromegaly in Greece. Is there any difference with other chronic diseases?The quality of life in acromegalic patients with biochemical remission by surgery alone is superior to that in those with pharmaceutical therapy without radiotherapy, using the newly developed Japanese version of the AcroQoL.Disease control and treatment modalities have impact on quality of life in acromegaly evaluated by Acromegaly Quality of Life (AcroQoL) Questionnaire.Normal long-term health-related quality of life can be achieved in patients with functional pituitary adenomas having surgery as primary treatment.Impact of treatment satisfaction on quality of life of patients with acromegaly.Evaluation of depressive mood and cognitive functions in patients with acromegaly under somatostatin analogue therapy.Effects of previous growth hormone excess and current medical treatment for acromegaly on cognition.Personality Traits and Physical Complaints in Patients With Acromegaly: A Cross Sectional Multi-Center Study With Analysis of Influencing Factors
P2860
Q31027960-CFF98802-8B70-4BAD-9860-41FD3F81A16EQ37530996-1AB9A6FE-7428-49C3-90B4-B3F0E216FD3BQ37678328-0E0C0C2E-30CF-4EF8-9413-EE776282C5FFQ38326160-41414E61-111E-4D61-B54D-876924A1AEC2Q38896036-F47CA671-1500-4849-A6E4-FFCC76D6E717Q38978491-7E26A4D5-A93A-43FA-8419-6CC9F075F62CQ40823732-5253FBC8-2E2F-405F-A2D2-914E87AF8EDDQ47919183-B47994B6-245B-4E78-A66F-D6E5B67058CBQ48021997-2F9BE621-FCD1-46DA-97BD-BCE467302421Q48054265-633B39A9-71A1-44BC-BA7F-71D1649199FEQ48070464-91C9E504-1BAD-4C8C-928D-ED4BB4AF83F9Q48116018-80FF2468-13C1-46A4-9F0A-6FD96E4A9629Q50433509-B7B29F36-43A0-401D-A6C0-1C06E58EB368Q50932230-0A51BB22-FFCB-4C0E-9617-E60EF7964C6DQ56526287-F62CA16E-AAA7-418F-B9AE-9E1C3FB789F9
P2860
Quality of life is impaired in association with the need for prolonged postoperative therapy by somatostatin analogs in patients with acromegaly.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Quality of life is impaired in ...... s in patients with acromegaly.
@en
Quality of life is impaired in ...... s in patients with acromegaly.
@nl
type
label
Quality of life is impaired in ...... s in patients with acromegaly.
@en
Quality of life is impaired in ...... s in patients with acromegaly.
@nl
prefLabel
Quality of life is impaired in ...... s in patients with acromegaly.
@en
Quality of life is impaired in ...... s in patients with acromegaly.
@nl
P2093
P356
P1476
Quality of life is impaired in ...... gs in patients with acromegaly
@en
P2093
Ad R M M Hermus
Alfons C M van den Bergh
Gerrit van den Berg
Jens Homan
Margreet A Wagenmakers
Mark R Postma
Romana T Netea-Maier
Wim J Sluiter
P304
P356
10.1530/EJE-11-0853
P577
2012-01-16T00:00:00Z